Fortis Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
1,159
+382
+49% +$131K 0.05% 269
2026
Q1
$273K Sell
777
-25
-3% -$8.91K 0.04% 313
2025
Q4
$263K Buy
+802
New +$254K 0.04% 261
2024
Q4
– Sell
-645
Closed -$208K – 173
2024
Q3
$208K Buy
+645
New +$211K 0.07% 169
2023
Q1
– Sell
-239
Closed -$62.8K – 659
2022
Q4
$62.8K Buy
+239
New +$64.1K 0.04% 273

Other funds holding AMGN

Fortis Capital Advisors's AMGN Position: Q2 2026 in Review

Fortis Capital Advisors increased its Amgen (AMGN) stake by 49% in Q2 2026, buying an estimated $131K and bringing the position to 1,159 shares worth $420K. The position accounts for 0.05% of the portfolio, ranked #269.

Fortis Capital Advisors first reported a position in AMGN in Q4 2022 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fortis Capital Advisors held 1,159 shares of Amgen worth $420K as of Q2 2026.
  • Fortis Capital Advisors bought 382 Amgen shares in Q2 2026, an estimated $131K.
  • Amgen made up 0.05% of Fortis Capital Advisors's portfolio in Q2 2026, its #269 holding.
  • Fortis Capital Advisors first reported a position in Amgen in Q4 2022 and has held it in 5 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.